Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Post by Leafs4Lifeon Nov 07, 2018 2:10pm
149 Views
Post# 28938617

Encouraging day for longs

Encouraging day for longsCongrats to longs today. It has been pretty damn ugly over the past few months but I'd say there are real reasons for optimism here.

1. LDS is (finally) back to doing disclosure in the proper fashion - under their own name.

We were told they were doing unorthodox disclosure (via CSPA) because of an issue with their Canadian bank - so it can be assumed that the banking pronblem has been resolved now that they are disclosing under LDS again. Positive newsflow will be a good thing for the share price going forward.

2. LDS delivered meaningful revenue for the second consecutive month. And that revenue is growing. 

They did over 1 million in revenue selling while label oils. We were told that the equipment was not functioning for 10 days in October so (fingers crossed) they will be able to grow on that revenue in November. Also, Reveur was only on sale in one dispensary. We should expect to see Reveur for sale in more locations this month - which could help grow revenue further. 

And when Reveur is delivered we might actually see disclosure about it because LDS is back to doing disclosure the right way again.

3. This is pure speculation but we have got to be getting close to seeing CannaStrips in a dispensary somewhere at some point. One would think the share price would get a boost once the flagship product is finally available for sale.  
Bullboard Posts